Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. JDOC: which is better?

Bottom line

PRHSX vs JDOC: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 58% by weight.

But PRHSX is far broader, holding 279 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 0.83% — a difference of $18 a year per $10,000 invested.

Over one year, PRHSX returned +17.7% vs +14.9% for JDOC.

Updated Nov 19, 2026

PRHSX vs JDOC side by side

PRHSXJDOC
TypeMutual fundETF
Fund familyT. Rowe PriceJ.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.65%
Annual cost per $10k$83$65
10-yr cost on $10k (prospectus)$1,025$810
Max front load—None
12b-1 fee——
1-yr return+17.7%+14.9%
5-yr return (annualized)+4.2%—
10-yr return (annualized)+9.1%—
Best quarter+23.5%+11.3%
Worst quarter−15.8%−11.9%
Net assets (fund)$11.9B$9.1M
Number of holdings27961
Portfolio turnover62%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXJDOCDifference
2025+17.7%+14.9%+2.8%
2024+1.8%−0.6%+2.5%

Source: Fund prospectus bar charts

Holdings overlap

13 of PRHSX's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingPRHSXJDOC
Eli Lilly & Co14.28%7.76%
Johnson & Johnson6.63%4.82%
Unitedhealth Group Inc5.99%5.85%
Abbvie Inc5.10%7.85%
Merck & Co. Inc.4.01%4.82%
Thermo Fisher Scientific Inc2.52%3.73%
Bristol-myers Squibb Co2.11%3.57%
Abbott Laboratories1.89%3.11%
Intuitive Surgical Inc1.87%1.93%
Stryker Corp1.78%2.23%
Danaher Corp1.43%2.16%
Cardinal Health Inc1.03%1.51%
Cvs Health Corp0.94%2.83%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between PRHSX and JDOC?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 58% by weight. But PRHSX is far broader, holding 279 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, PRHSX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both PRHSX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.